A carregar...
Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists
Sipuleucel-T represents a novel immunotherapeutic compound designed to stimulate an immune response against castration-resistant prostate cancer (CRPC). Sipuleucel-T is an autologous active cellular immunotherapy product, which includes autologous dendritic cells pulsed ex vivo with PAP2024, a recom...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126040/ https://ncbi.nlm.nih.gov/pubmed/21789160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834010397692 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|